Organon (OGN) Change in Inventory (2020 - 2026)
Organon (OGN) posted quarterly Change in Inventory of $15.0 million for Q2 2026, down 55.88% year-over-year from $34.0 million in Q2 2025, and up 66.67% on a QoQ basis from $9.0 million in Q1 2026.
Organon (OGN) Change in Inventory (2020 - 2026) Analysis & Trends
Organon has reported Change in Inventory for 7 years, with the latest figure at $15.0 million in Q2 2026.
- Change in Inventory for Q2 2026 came in at $15.0 million, down 55.88% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.0 million (down 95.12% YoY), and the FY2025 annual result was $13.0 million, down 90.08% from the prior year.
- Change in Inventory grew to $15.0 million in Q2 2026, from $9.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $95.0 million in Q2 2022 and troughed at -$81.0 million in Q4 2025.
- A 5-year average of $34.3 million and a median of $36.0 million in 2023 frame the typical range for Change in Inventory.
- The widest annual swing landed in 2025, when Change in Inventory sank 361.29%; it then soared 400.0% in 2026.
- A 5-year view of Change in Inventory shows it stood at $86.0 million in 2022, then increased by 8.14% to $93.0 million in 2023, then plunged by 66.67% to $31.0 million in 2024, then tumbled by 361.29% to -$81.0 million in 2025, then soared by 118.52% to $15.0 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $15.0 million in Q2 2026, $9.0 million in Q1 2026, and -$81.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 31.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 145.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 15.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.00 Mn |
| Jun 30, 2026 | 15.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | -81.00 Mn |
| Dec 31, 2025 | -81.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Jun 30, 2024 | 58.00 Mn |
| Jun 30, 2024 | 58.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Mar 31, 2024 | -19.00 Mn |